查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
去细胞真皮基质 (ADM)植入：全球和区域市场分析与预测 (2024-2030)
市场调查报告书
商品编码
1389928

去细胞真皮基质 (ADM)植入：全球和区域市场分析与预测 (2024-2030)

Acellular Dermal Matrix Implant Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2030
出版日期: 按订单生产 | 出版商: BIS Research | 英文 | 商品交期: 7-10个工作天内

价格
简介目录

预计到 2030 年，全球去细胞真皮基质 (ADM)植入市场规模将成长至超过 10 亿美元。

该市场是由需要组织再生和重组的烧烫伤、伤口和感染疾病等慢性疾病日益流行所推动的。此外，对微创手术不断增长的需求正在推动对 ADM植入的需求，因为植入可用于各种微创手术。

按类型来看，人类皮肤部门由于其生物相容性和低排斥风险预计将占据最大占有率。此外，从应用来看，由于ADM在整形外科领域的广泛应用，预计整形外科部门将占最大占有率。此外，从地区来看，由于慢性病患病率高且医疗基础设施发达，北美预计将占据最大占有率。同时，由于该地区对 ADM 的需求不断增加，预计亚洲将成为成长最快的市场。

本报告调查了全球去细胞真皮基质（ADM）植入市场，并提供了市场背景和概述，分析了市场成长的各种影响因素、研发趋势、法律制度、市场规模趋势和预测，我们总结了详细分析：各类别/地区/主要国家、竞争形势、主要企业分析等

目录

第一章市场：产业展望

  • 趋势：当前和未来的影响评估
  • 供应链概览
    • 价值链分析
    • 市场地图
    • 价格预测
  • 研发回顾
    • 按国家和公司分類的专利申请趋势
  • 监管状况
  • 利害关係人分析
    • 使用案例
    • 最终用户和购买标准
  • 市场动态概览
    • 市场驱动因素
    • 市场抑制因素
    • 市场机会
  • 启动资金筹措：摘要

第二章去细胞真皮基质（ADM）植入市场：依应用分类

  • 使用分类
  • 应用概述
  • 整形外科
    • 乳房重建
    • 脸部重组
    • 腹部整形术
    • 其他的
  • 妇科
    • 应力性尿失禁
    • 骨盆器官脱垂
    • 阴道瘻管重组
    • 其他的
  • 其他的
    • 创伤治疗
    • 烧烫伤修復
    • 牙科
    • 整形外科

第三章去细胞真皮基质（ADM）植入市场：依产品类型

  • 产品分类
  • 产品概要
  • 人的皮肤
    • 同种异体的
    • 自体的
  • 动物皮
    • 猪
    • 牛
    • 其他的

第四章去细胞真皮基质（ADM）植入市场：依地区

  • 区域概况
  • 促进因素/抑制因素
  • 北美洲
    • 市场
    • 目的
    • 产品
    • 按国家/地区
  • 欧洲
    • 市场
    • 目的
    • 产品
    • 按国家/地区
  • 亚太地区
    • 市场
    • 目的
    • 产品
    • 按国家/地区

第五章市场：竞争形势/公司简介

  • 竞争形势
  • 公司简介
    • Zimmer Biomet
    • Allergan
    • Stryker
    • MTF Biologics
    • LifeNet Health
    • Integra LifeSciences
    • Medtronic
    • Arthrex
    • Straumann
    • Wright Medical Group
    • Hans Biomed
    • Xtant Medical

第 6 章 成长机会/建议

第七章调查方法

简介目录
Product Code: BHM1583SA

The global acellular dermal matrix (ADM) implants market is expected to cross $1 billion by 2030. ADMs are scaffolds derived from animal or human skin that are used to regenerate and reinforce damaged tissues. They are commonly used in plastic surgery, gynecology, and other reconstructive procedures.

The global acellular dermal matrix (ADM) implants market is driven by the increasing prevalence of chronic conditions such as burns, wounds, and infections, which require tissue regeneration and reconstruction. Additionally, the growing demand for minimally invasive procedures is driving the demand for ADM implants, as they can be used in a variety of minimally invasive procedures.

The global acellular dermal matrix (ADM) implants market is segmented by type, application, and region. By type, the human skin segment is expected to hold the largest market share due to its biocompatibility and low risk of rejection. By application, the plastic surgery segment is expected to hold the largest market share due to the wide range of applications of ADMs in plastic surgery procedures.

North America is expected to hold the largest market share due to the high prevalence of chronic conditions and the well-developed healthcare infrastructure in the region. However, Asia is expected to be the fastest-growing market due to the increasing demand for ADMs in the region.

The ADM implants market is characterized by the presence of both large multinational corporations and smaller regional players.

Some of the key players in the market include:

  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • MiMedx Group, Inc.
  • LifeCell Corporation
  • AlloSource LLC

These companies are engaged in research and development to expand their product offerings and improve the performance of their ADMs. They are also actively pursuing strategic partnerships and acquisitions to expand their market reach and strengthen their competitive positions.

Table of Contents

1. Markets: Industry Outlook

  • 1.1. Trends: Current and Future Impact Assessment
  • 1.2. Supply Chain Overview
    • 1.2.1. Value chain Analysis
    • 1.2.2. Market Map
    • 1.2.3. Pricing Forecast
  • 1.3. R&D Review
    • 1.3.1. Patent Filing Trend by Country, by Company
  • 1.4. Regulatory Landscape
  • 1.5. Stakeholder Analysis
    • 1.5.1. Use Case
    • 1.5.2. End User and buying criteria
  • 1.6. Market Dynamics Overview
    • 1.6.1. Market Drivers
    • 1.6.2. Market Restraints
    • 1.6.3. Market Opportunities
  • 1.7. Startup Funding Summary

2. Acellular Dermal Matrix Implants Market by Application

  • 2.1. Application Segmentation
  • 2.2. Application Summary
  • 2.3. Plastic Surgery
    • 2.3.1. Breast Reconstruction
    • 2.3.2. Facial Reconstruction
    • 2.3.3. Abdominoplasty
    • 2.3.4. Other
  • 2.4. Gynecology
    • 2.4.1. Stress Urinary Incontinence
    • 2.4.2. Pelvic Organ Prolapse
    • 2.4.3. Reconstruction of Vaginal Fistulas
    • 2.4.4. Other
  • 2.5. Others
    • 2.5.1. Wound Healing
    • 2.5.2. Burn Repair
    • 2.5.3. Dental Applications
    • 2.5.4. Orthopedic Applications

3. Acellular Dermal Matrix Implants Market by Product Type

  • 3.1. Product Segmentation
  • 3.2. Product Summary
  • 3.3. Human Skin
    • 3.3.1. Allogenic
      • 3.3.1.1. Dermal Matrix
      • 3.3.1.2. Fat Grafts
    • 3.3.2. Autologous
      • 3.3.2.1. Dermal Matrix
      • 3.3.2.2. Fat Grafts
  • 3.4. Animal Skin
    • 3.4.1. Porcine
    • 3.4.2. Bovine
    • 3.4.3. Other

4. Acellular Dermal Matrix Implants Market by Region

  • 4.1. Regional Summary
  • 4.2. Drivers and Restraints
  • 4.3. North America
    • 4.3.1. Markets
      • 4.3.1.1. Key Market Participants in North America
      • 4.3.1.2. Business Drivers
      • 4.3.1.3. Business Challenges
    • 4.3.2. Application
    • 4.3.3. Product
    • 4.3.4. North America by Country
      • 4.3.4.1. U.S.
      • 4.3.4.2. Canada
  • 4.4. Europe
    • 4.4.1. Markets
      • 4.4.1.1. Key Market Participants in Europe
      • 4.4.1.2. Business Drivers
      • 4.4.1.3. Business Challenges
    • 4.4.2. Application
    • 4.4.3. Product
    • 4.4.4. Europe by Country
      • 4.4.4.1. U.K.
      • 4.4.4.2. Germany
      • 4.4.4.3. France
  • 4.5. Asia-Pacific
    • 4.5.1. Markets
      • 4.5.1.1. Key Market Participants in Asia-Pacific
      • 4.5.1.2. Business Drivers
      • 4.5.1.3. Business Challenges
    • 4.5.2. Application
    • 4.5.3. Product
    • 4.5.4. Asia-Pacific by Country
      • 4.5.4.1. China
      • 4.5.4.2. Japan
      • 4.5.4.3. India

5. Markets - Competitive Landscape & Company Profiles

  • 5.1. Competitive Landscape
  • 5.2. Company Profiles
    • 5.2.1. Zimmer Biomet
      • 5.2.1.1. Company Overview
      • 5.2.1.2. Top Products / Product Portfolio
      • 5.2.1.3. Top Competitors
      • 5.2.1.4. Target Customers /End-Users
      • 5.2.1.5. Key Personnel
      • 5.2.1.6. Market Share
      • 5.2.1.7. Analyst View
    • 5.2.2. Allergan
      • 5.2.2.1. Company Overview
      • 5.2.2.2. Top Products / Product Portfolio
      • 5.2.2.3. Top Competitors
      • 5.2.2.4. Target Customers /End-Users
      • 5.2.2.5. Key Personnel
      • 5.2.2.6. Market Share
      • 5.2.2.7. Analyst View
    • 5.2.3. Stryker
      • 5.2.3.1. Company Overview
      • 5.2.3.2. Top Products / Product Portfolio
      • 5.2.3.3. Top Competitors
      • 5.2.3.4. Target Customers /End-Users
      • 5.2.3.5. Key Personnel
      • 5.2.3.6. Market Share
      • 5.2.3.7. Analyst View
    • 5.2.4. MTF Biologics
      • 5.2.4.1. Company Overview
      • 5.2.4.2. Top Products / Product Portfolio
      • 5.2.4.3. Top Competitors
      • 5.2.4.4. Target Customers /End-Users
      • 5.2.4.5. Key Personnel
      • 5.2.4.6. Market Share
      • 5.2.4.7. Analyst View
    • 5.2.5. LifeNet Health
      • 5.2.5.1. Company Overview
      • 5.2.5.2. Top Products / Product Portfolio
      • 5.2.5.3. Top Competitors
      • 5.2.5.4. Target Customers /End-Users
      • 5.2.5.5. Key Personnel
      • 5.2.5.6. Market Share
      • 5.2.5.7. Analyst View
    • 5.2.6. Integra LifeSciences
      • 5.2.6.1. Company Overview
      • 5.2.6.2. Top Products / Product Portfolio
      • 5.2.6.3. Top Competitors
      • 5.2.6.4. Target Customers /End-Users
      • 5.2.6.5. Key Personnel
      • 5.2.6.6. Market Share
      • 5.2.6.7. Analyst View
    • 5.2.7. Medtronic
      • 5.2.7.1. Company Overview
      • 5.2.7.2. Top Products / Product Portfolio
      • 5.2.7.3. Top Competitors
      • 5.2.7.4. Target Customers /End-Users
      • 5.2.7.5. Key Personnel
      • 5.2.7.6. Market Share
      • 5.2.7.7. Analyst View
    • 5.2.8. Arthrex
      • 5.2.8.1. Company Overview
      • 5.2.8.2. Top Products / Product Portfolio
      • 5.2.8.3. Top Competitors
      • 5.2.8.4. Target Customers /End-Users
      • 5.2.8.5. Key Personnel
      • 5.2.8.6. Market Share
      • 5.2.8.7. Analyst View
    • 5.2.9. Straumann
      • 5.2.9.1. Company Overview
      • 5.2.9.2. Top Products / Product Portfolio
      • 5.2.9.3. Top Competitors
      • 5.2.9.4. Target Customers /End-Users
      • 5.2.9.5. Key Personnel
      • 5.2.9.6. Market Share
      • 5.2.9.7. Analyst View
    • 5.2.10. Wright Medical Group
      • 5.2.10.1. Company Overview
      • 5.2.10.2. Top Products / Product Portfolio
      • 5.2.10.3. Top Competitors
      • 5.2.10.4. Target Customers /End-Users
      • 5.2.10.5. Key Personnel
      • 5.2.10.6. Market Share
      • 5.2.10.7. Analyst View
    • 5.2.11. Hans Biomed
      • 5.2.11.1. Company Overview
      • 5.2.11.2. Top Products / Product Portfolio
      • 5.2.11.3. Top Competitors
      • 5.2.11.4. Target Customers /End-Users
      • 5.2.11.5. Key Personnel
      • 5.2.11.6. Market Share
      • 5.2.11.7. Analyst View
    • 5.2.12. Xtant Medical
      • 5.2.12.1. Company Overview
      • 5.2.12.2. Top Products / Product Portfolio
      • 5.2.12.3. Top Competitors
      • 5.2.12.4. Target Customers /End-Users
      • 5.2.12.5. Key Personnel
      • 5.2.12.6. Market Share
      • 5.2.12.7. Analyst View

6. Growth Opportunities & Recommendations

7. Research Methodology